By Shahzad Malik
ISLAMABAD: Federal Investigation Agency (FIA) has initiated probe against CEO DRAP Asim Rauf for awarding substandard syringes contract.
According to the case, Asim Rauf awarded contract to a company who imported substandard syringes which were found a major cause of spread of diseases in the people, a complainant filed with the FIA.
Anti-corruption circle of the Federal Investigation Agency has formally started an investigation in this regard and the syringes contract that DRAP has given to the private company are non-standard that are spreading diseases and these syringes are substandard according to investigation.
FIA has issued a notice to the Collector of Customs for production of records and FIA also served notice to CEO DRAP Asim Rauf for investigation. In notice for record to Pakistan Customs, FIA asked for a copy of general declaration regarding import of non medical grade poly propylene fringes, 1-4 infusion set etc with NOC of the DRAP.
FIA further asked in the notice that the data of import general declaration of non medical poly propylene syringes 1-4 infusion set of last 6 month of MS Unsia Private Limited and Albader Manufacturing Limited and data of similar types of permission of general general declaration of other companies.
FIA also seek record and copy of NOC from ministry of health, DRAP and other departments and detail of all other import items of such type of goods and any other related information regarding subjects matter.
On this matter, this reporter called couple of times to CEO DRAP Asim Rauf for point of view but he did not respond.
